Seeing out 2024, IPT Winter shows no sign of slowing down for the holiday season – with many featured companies looking steadfastly into 2025 and all that next year may hold.
Kicking the edition off is IPT’s second iteration of Product News, featuring bite-sized pieces about the latest product and manufacturing news from companies such as ZEISS, Ardena and TaBlitz (page 8). This is followed by the Royal Microscopical Society round-up (page 10), which highlights some of the most exciting news to come from the organisation in the latter half of 2024, including a review of its ‘Microscopy: Advances, Innovation, Impact 2024 – incorporating the RMS AGM & Section AGMs’ event.
When manufacturing pharmaceuticals, a company is only as good as its machinery and workforce; Natoli showcases its top-of-the-line tablet and capsule compression tooling machines (page 12), while CARBOGEN AMCIS discusses the importance of managing talent in a contract development and manufacturing organisation (page 14).
The world is becoming more and more digitalised as time goes on, and this is no different in the pharma sector. Hot topic tools such as generative artificial intelligence (genAI) (Iktos, page 26) and cloud computing (SciY, page 32) are increasingly being used in drug development, with AI usage now being commonplace in life sciences data programming, safety and pharmacovigilance, and medical monitoring, among other elements (Hexaware, page 34).
Bringing this edition of IPT Winter to a close, Labforward talks about AI’s use in connecting labs and creating digital lab assistants to aid pharma research (page 46) – a futuristic concept already in place and showing that anything is possible as we look into the new year.
Don’t forget to look back at this year’s magazines to recap on some of the most interesting topics in pharmaceutical technology; we’ll see you in 2025 with more insights from the sector’s leading voices.
James Spargo
Deputy Editor